| XLS |
|
|
|
|
|
|
€ million |
Note |
Dec. 31, 2013 |
Dec. 31, 2012 |
|
Current assets |
|
|
|
|
Cash and cash equivalents |
[35] |
980.8 |
729.7 |
|
Current financial assets |
[36] |
2,410.5 |
1,797.9 |
|
Trade accounts receivable |
[37] |
2,021.4 |
2,114.6 |
|
Inventories |
[38] |
1,474.2 |
1,533.9 |
|
Other current assets |
[39] |
360.7 |
271.5 |
|
Income tax receivables |
[40] |
109.8 |
178.5 |
|
Assets held for sale |
[4] |
27.1 |
– |
|
|
|
7,384.5 |
6,626.1 |
|
Non-current assets |
|
|
|
|
Intangible assets |
[41] |
9,867.2 |
10,944.5 |
|
Property, plant and equipment |
[42] |
2,647.2 |
2,953.6 |
|
Non-current financial assets |
[43] |
77.8 |
97.1 |
|
Other non-current assets |
[39] |
105.5 |
75.4 |
|
Deferred tax assets |
[32] |
736.4 |
946.6 |
|
|
|
13,434.1 |
15,017.2 |
|
|
|
|
|
|
Total assets |
|
20,818.6 |
21,643.3 |
|
|
|
|
|
|
Current liabilities |
|
|
|
|
Current financial liabilities |
[44] |
440.4 |
1,091.4 |
|
Trade accounts payable |
[45] |
1,364.1 |
1,288.3 |
|
Other current liabilities |
[46] |
1,134.5 |
1,096.2 |
|
Income tax liabilities |
[47] |
465.1 |
401.4 |
|
Current provisions |
[48] |
494.7 |
684.3 |
|
Liabilities directly related to assets held for sale |
[4] |
– |
– |
|
|
|
3,898.8 |
4,561.6 |
|
Non-current liabilities |
|
|
|
|
Non-current financial liabilities |
[44] |
3,257.5 |
3,362.1 |
|
Other non-current liabilities |
[46] |
5.6 |
9.4 |
|
Non-current provisions |
[48] |
1,011.1 |
891.7 |
|
Provisions for pensions and other post-employment benefits |
[49] |
910.9 |
1,211.7 |
|
Deferred tax liabilities |
[32] |
665.5 |
1,192.0 |
|
|
|
5,850.6 |
6,666.9 |
|
Equity |
[50] |
|
|
|
Equity capital |
|
565.2 |
565.2 |
|
Reserves |
|
9,341.1 |
8,552.3 |
|
Gains/losses recognized immediately in equity |
|
1,113.7 |
1,243.9 |
|
Equity attributable to Merck KGaA shareholders |
|
11,020.0 |
10,361.4 |
|
Non-controlling interests |
|
49.2 |
53.4 |
|
|
|
11,069.2 |
10,414.8 |
|
|
|
|
|
|
Total liabilities and equity |
|
20,818.6 |
21,643.3 |